Schedule 13D ownership disclosure

VeraDermics, Inc.

Common Stock, $0.00001 par value per share · CUSIP: 922967104

Event date: 2026-11-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Longitude Capital Partners V, LLCReported CIK 0002018312

    Shares: 2,350,399 · Class: 5.6%

  • Longitude Venture Partners V, L.P.Reported CIK 0001935964

    Shares: 2,350,399 · Class: 5.6%

  • Longitude 103.8 East Partners, LLCReported CIK 0002094273

    Shares: 1,803,474 · Class: 4.3%

  • Longitude 103.8 East, L.P.Reported CIK 0002094269

    Shares: 1,803,474 · Class: 4.3%

  • Patrick G. EnrightReported CIK 0001253886

    Shares: 4,153,873 · Class: 9.8%

  • Juliet Tammenoms BakkerReported CIK 0001431159

    Shares: 4,153,873 · Class: 9.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-461091
Form type
SCHEDULE 13D/A
Filer
Longitude Capital Partners V, LLC
CIK
CIK 2018312
Filed
Nov 13, 2026
Reporting period
Nov 11, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub